| Literature DB >> 24321092 |
Supargiyono Supargiyono1, Michael T Bretscher, Mahardika A Wijayanti, Inge Sutanto, Dian Nugraheni, Royhan Rozqie, Ayleen A Kosasih, Sulistyawati Sulistyawati, William A Hawley, Neil F Lobo, Jackie Cook, Chris J Drakeley.
Abstract
BACKGROUND: The transmission of malaria in Indonesia is highly heterogeneous spatially and seasonally. Anti-malaria antibody responses can help characterize this variation. In the present study antibody responses to Plasmodium falciparum MSP-1 and AMA-1 were measured to assess the transmission intensity in a hypo-endemic area of Purworejo and a meso-endemic area of Lampung during low and high transmission seasons.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24321092 PMCID: PMC3866602 DOI: 10.1186/1475-2875-12-444
Source DB: PubMed Journal: Malar J ISSN: 1475-2875 Impact factor: 2.979
Figure 1Study site: District of Purworejo (hypoendemic) and South Lampung (mesoendemic).
Figure 2The monthly slide positivity rate (SPR) from November 2008 to September 2009 in Lampung and Purworejo. Arrows show the time of bloodspot collection during high (left) and low (right) season.
Antibody prevalence to merozoite antigens by site and transmission season
**p < 0.001, *p < 0.05 – designate chi-squared test between seasons for each site.
Prevalence and magnitude of antibody response to merozoite antigens by age group in Lampung
| Low | PfMSP1-19 | Prevalence | 0 (62) | 1.3(96) | 15.5(84) | 43.1(58) | 61.8(123) | 61.7(94) |
| Mean OD | 0.080 | 0.081 | 0.11 | 0.182 | 0.263 | 0.329 | ||
| High | PfMSP1-19 | Prevalence | 6.9(72) | 8.4(71) | 22.1(68) | 46.1(65) | 63.4(134) | 91.2(80) |
| Mean OD | 0.083 | 0.096 | 0.125 | 0.164 | 0.247 | 0.460 | ||
| Low | PfAMA1 | Prevalence | 3.2(62) | 3.2(96) | 22.6(84) | 43.1(58) | 66.7(123) | 67.0(94) |
| Mean OD | 0.091 | 0.078 | 0.111 | 0.161 | 0.272 | 0.324 | ||
| High | PfAMA1 | Prevalence | 6.9(72) | 14.1(71) | 20.6(68) | 47.7(65) | 58.2(134) | 78.7(80) |
| Mean OD | 0.072 | 0.100 | 0.111 | 0.168 | 0.247 | 0.429 | ||
| Low | Combined | Prevalence | 5.0(62) | 16.7(96) | 38.1(84) | 58.6(58) | 78.5(123) | 80.5(94) |
| High | Prevalence | 16.8(72) | 25.3(71) | 44.1(68) | 60.0(65) | 66.4(134) | 95.0(80) |
Figure 3Age seroprevalence plots with fitted seroconversion line for PfMSP1-19 in Lampung (a & b) and in Purowejo (c & d) during low and high season. Red triangles indicate observed sero prevalence and solid blue lines show model-predicted seroprevalence. Broken blue lines are 95% confidence intervals.
Prevalence and magnitude of antibody response to merozoite antigens by age group in Purworejo
| Low | PfMSP1-19 | Prevalence | 1.6(62) | 1.3(77) | 7.6(66) | 8.5(71) | 12.7(115) | 22.7(97) |
| Mean OD | 0.067 | 0.071 | 0.085 | 0.093 | 0.113 | 0.142 | ||
| High | PfMSP1-19 | Prevalence | 5.6(71) | 5.4(74) | 8.1(74) | 18.4(76) | 23.7(118) | 35.1(114) |
| Mean OD | 0.081 | 0.091 | 0.104 | 0.133 | 0.154 | 0.192 | ||
| Low | PfAMA1 | Prevalence | 3.2(62) | 5.4(77) | 12.1(66) | 12.7(71) | 14.8(115) | 32.0(97) |
| Mean OD | 0.059 | 0.064 | 0.085 | 0.093 | 0.101 | 0.148 | ||
| High | PfAMA1 | Prevalence | 5.6(71) | 6.8(74) | 6.8(74) | 17.1(76) | 23.7(118) | 41.2(114) |
| Mean OD | 0.079 | 0.076 | 0.084 | 0.138 | 0.146 | 0.191 | ||
| Low | Combined | Prevalence | 4.8(62) | 9.1(77) | 16.7(66) | 21.1(71) | 30.4(115) | 52.6(97) |
| High | Prevalence | 11.2(71) | 18.9(74) | 27.0(74) | 42.1(76) | 50.0(118) | 57.0(114) |
Figure 4Age seroprevalence plots with fitted seroconversion line for PfAMA1 in Lampung (a & b) and in Purowejo (c & d) during low and high season. Red triangles indicate observed sero prevalence and solid blue lines show model-predicted seroprevalence. Broken blue lines are 95% confidence intervals.
Figure 5Age seroprevalence plots with fitted seroconversion line for combined (PfMSP1-19 and PfAMA1) antibody response in Lampung (a & b) and in Purowejo (c & d) during low and high season. Red triangles indicate observed sero prevalence and solid blue lines show model-predicted seroprevalence. Broken blue lines are 95% confidence intervals.
Figure 6Reverse cumulative distribution plots to compare antibody responses to MSP1-19 between seasons in Lampung (a) and Purworejo (b).
Seroconversion rates for merozoite antigens using age specific sero-prevalence
| aPfMSP1-19 | | | | |
| Current | 0.004 (0.001-0.01) | 0.013 (0.007-0.02) | 0.006 (0.004-0.008) | 0.011 (0.009-0.014) |
| Previous | 0.067 (0.05-0.087) | 0.091 (0.07-0.12) | | |
| bPfAMA1 | | | | |
| Current | 0.007 (0.003-0.014) | 0.019 (0.011-0.031) | 0.009 (0.007-0.012) | 0.013 (0.01-0.016) |
| Previous | 0.096 (0.072-0.12) | 0.078 (0.056-0.11) | | |
| bCombined | | | | |
| Current | 0.035 (0.026-0.049) | 0.053 (0.039-0.073) | 0.019 (0.015-0.022) | 0.032 (0.03-0.038) |
| Previous | 0.124 (0.084-0.18) | 0.091 (0.058-0.14) | ||
#for Lampung a model with two separate forces of infection (with a change point 10 years before present) fitted the data better than a model with a single force of infection.
afor PfMSP1-19 the rate of reversion in the seroconversion models was restricted to 0.017.
bfor PfAMA1 and the combined antibody response the rate of reversion in the seroconversion models was restricted to 0.026.
Figure 7Reverse cumulative distribution plots to compare antibody responses to to AMA-1 between seasons in Lampung and Purworejo. a. Lampung*) Wilcoxon rank sum test shows significant difference in antibody levels between season (P < 0.001). b. Purworejo**) Wilcoxon rank sum test shows significant difference in antibody levels between season (P < 0.0001).